Maximus Inc (MMS) Q2 2026 Earnings Call Transcript

Why It Matters

The upgraded outlook underscores Maximus' ability to translate technology investments into higher margins and cash generation, reinforcing its competitive position in the government services market. Persistent DSO pressure and international losses highlight liquidity and scaling challenges that investors must monitor.

Key Takeaways

• Revenue $1.31B, meets guidance
• Adjusted EBITDA margin 14.4%, up YoY
• Share repurchases $151M, program refreshed to $400M
• DSO elevated at 78 days, liquidity risk
• AI automation fuels margin improvement

Pulse Analysis

Maximus, a leading provider of government‑contracted health and human services, posted a solid second‑quarter performance that reflects the payoff of its multiyear technology transformation. By embedding AI tools such as TXM and Accuracy Assistant into core programs, the firm trimmed labor intensity and lifted the U.S. Federal Services margin to 17.6%, while the overall adjusted EBITDA margin climbed to 14.4%. These efficiency gains helped offset a modest revenue dip in the U.S. Services segment and an asset impairment charge, delivering adjusted earnings per share of $2.07.

The financial picture is further strengthened by robust cash generation. Free cash flow reached $179 million, supporting an aggressive share‑repurchase strategy that saw $151 million returned to shareholders this quarter and a refreshed $400 million buyback ceiling. Net leverage improved to 1.8×, comfortably below the company’s 2‑3× target, and total debt slipped to $1.55 billion. However, an elevated Days Sales Outstanding of 78 days, driven by a major federal customer’s billing delays, remains a near‑term liquidity concern that management expects to resolve before fiscal year‑end.

Looking ahead, Maximus raised its full‑year revenue outlook to $5.2‑$5.35 billion and nudged adjusted EPS guidance up by $0.20, signaling confidence in its pipeline of $56.8 billion in contract value. The company’s focus on AI‑driven automation, combined with a growing H.R. 1‑related opportunity set, positions it to capture additional federal and state contracts. Yet, scaling the Outside‑the‑U.S. segment and managing DSO pressures will be critical to sustaining margin expansion and delivering on the upgraded earnings forecast.